ADIM
AFRM icon

Alpha DNA Investment Management’s Affirm AFRM Stock Holding History

Alpha DNA Investment Management’s Portfolio AFRM Stock Details AFRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,674
Closed -$772K – 16
2024
Q4 		$772K Buy
12,674
+1,871
+17% +$104K 0.29% 77
2024
Q3 		$441K Sell
10,803
-2,924
-21% -$97K 0.17% 152
2024
Q2 		$415K Buy
+13,727
New +$440K 0.16% 152

Other funds holding AFRM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Alpha DNA Investment Management's AFRM Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Affirm (AFRM) in Q1 2025, closing a stake of 12,674 shares — an estimated $772K sold.

Alpha DNA Investment Management first reported a position in AFRM in Q2 2024 and held it in 3 quarters. The position peaked at $772K in Q4 2024. 490 funds tracked by Wall St. Rank hold AFRM as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Affirm position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 12,674 Affirm shares in Q1 2025, an estimated $772K.
  • Alpha DNA Investment Management first reported a position in Affirm in Q2 2024 and held it in 3 quarters.
  • Alpha DNA Investment Management's Affirm position peaked at $772K in Q4 2024.
  • 490 funds tracked by Wall St. Rank held Affirm as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.